The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013

[1]  Gérard Krause,et al.  Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013 , 2015, The Lancet.

[2]  Nobhojit Roy,et al.  The Global Burden of Cancer 2013. , 2015, JAMA oncology.

[3]  Dan J Stein,et al.  Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[4]  G. Cooke,et al.  Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  T. Vos,et al.  Assessing disability weights based on the responses of 30,660 people from four European countries , 2015, Population Health Metrics.

[6]  Bernadette A. Thomas,et al.  Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[7]  N. Ford,et al.  Viral hepatitis and the Global Burden of Disease: a need to regroup , 2013, Journal of viral hepatitis.

[8]  John McNally,et al.  Sofosbuvir for previously untreated chronic hepatitis C infection. , 2013, The New England journal of medicine.

[9]  A. Flaxman,et al.  Global epidemiology of hepatitis C virus infection: New estimates of age‐specific antibody to HCV seroprevalence , 2013, Hepatology.

[10]  T. Pilot‐Matias,et al.  Exploratory study of oral combination antiviral therapy for hepatitis C. , 2013, The New England journal of medicine.

[11]  Mohsen Naghavi,et al.  GBD 2010: design, definitions, and metrics , 2012, The Lancet.

[12]  Gretchen A. Stevens,et al.  The global burden of hepatitis E virus genotypes 1 and 2 in 2005 , 2012, Hepatology.

[13]  Gretchen A. Stevens,et al.  Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. , 2012, Vaccine.

[14]  J. Salomon.  New disability weights for the global burden of disease. , 2010, Bulletin of the World Health Organization.

[15]  K. Jacobsen,et al.  Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. , 2010, Vaccine.

[16]  N. Xia,et al.  Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial , 2010, The Lancet.

[17]  N. Xia,et al.  Effi cacy and safety of a recombinant hepatitis E vaccine in healthy adults : a large-scale , randomised , double-blind placebo-controlled , phase 3 trial , 2010 .

[18]  L. Finelli,et al.  Cost-Effectiveness of Routine Childhood Vaccination for Hepatitis A in the United States , 2007, Pediatrics.

[19]  Xiaomei Ma,et al.  Global Burden of Cancer , 2006, The Yale journal of biology and medicine.

[20]  Jennifer A. Roberts,et al.  Health benefits of antiviral therapy for mild chronic hepatitis C: randomised controlled trial and economic evaluation. , 2006, Health technology assessment.

[21]  P. Whiting,et al.  A systematic review of the effectiveness and cost-effectiveness of neuroimaging assessments used to visualise the seizure focus in people with refractory epilepsy being considered for surgery. , 2006, Health technology assessment.

[22]  P. Lopalco,et al.  Case fatality rate of acute viral hepatitis in Italy: 1995-2000. An update. , 2003, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[23]  B. Bell,et al.  Hepatitis A virus infections in the United States: model-based estimates and implications for childhood immunization. , 2002, Pediatrics.

[24]  T. Wright,et al.  Acute hepatitis C , 2001, Hepatology.

[25]  P. Marcellin,et al.  Hepatitis C: the clinical spectrum of the disease. , 1999, Journal of hepatology.

[26]  L. Seeff,et al.  Natural history of hepatitis C , 1997, Hepatology.

[27]  E. Balocchini,et al.  Case fatality rate of acute hepatitis in Italy: results from a 10 year surveillance. , 1997, Scandinavian journal of infectious diseases.

[28]  T R Bender,et al.  Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. , 1985, The Journal of infectious diseases.

[29]  R. W. Mccollum.  The natural history of hepatitis. , 1969, Bulletin of the New York Academy of Medicine.

[30]  J. Herrera,et al.  Hepatitis E virus infection , 2018, Nature Reviews Disease Primers.